BVS
Bioventus Inc
NASDAQ: BVS · HEALTHCARE · MEDICAL DEVICES
$9.87
+2.07% today
Updated 2026-04-30
Market cap
$682.47M
P/E ratio
30.58
P/S ratio
1.20x
EPS (TTM)
$0.33
Dividend yield
—
52W range
$6 – $11
Volume
0.4M
Bioventus Inc (BVS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $232.38M | $242.89M | $253.65M | $274.50M | $292.06M | $319.18M | $340.14M | $321.16M | $430.90M | $512.12M | $512.35M | $573.28M | $568.09M |
| Revenue growth (YoY) | — | +4.5% | +4.4% | +8.2% | +6.4% | +9.3% | +6.6% | -5.6% | +34.2% | +18.8% | +0.0% | +11.9% | -0.9% |
| Cost of revenue | $71.37M | $74.61M | $74.34M | $91.39M | $92.10M | $84.17M | $90.94M | $87.64M | $128.19M | $181.04M | $184.15M | $185.05M | $185.66M |
| Gross profit | $161.00M | $168.28M | $179.31M | $183.11M | $199.96M | $235.01M | $249.21M | $233.52M | $302.71M | $331.08M | $328.19M | $388.23M | $382.43M |
| Gross margin | 69.3% | 69.3% | 70.7% | 66.7% | 68.5% | 73.6% | 73.3% | 72.7% | 70.3% | 64.6% | 64.1% | 67.7% | 67.3% |
| R&D | $10.94M | $9.46M | $14.75M | $7.90M | $8.10M | $8.10M | $11.05M | $11.20M | $19.04M | $23.85M | $13.45M | $13.64M | $12.11M |
| SG&A | — | — | — | — | — | $191.67M | $196.12M | $190.31M | $250.38M | $326.93M | $300.03M | $322.67M | $314.03M |
| Operating income | $-8.07M | $20000.00 | $-16.59M | $14.89M | $27.02M | $25.50M | $31.19M | $21.24M | $12.06M | $-167.23M | $-81.72M | $-11.98M | $58.55M |
| Operating margin | -3.5% | 0.0% | -6.5% | 5.4% | 9.3% | 8.0% | 9.2% | 6.6% | 2.8% | -32.7% | -16.0% | -2.1% | 10.3% |
| EBITDA | $15.68M | $29.30M | $15.18M | $44.05M | $59.85M | $54.52M | $61.58M | $54.31M | $45.48M | $-121.61M | $-23.07M | $39.22M | $105.56M |
| EBITDA margin | 6.7% | 12.1% | 6.0% | 16.0% | 20.5% | 17.1% | 18.1% | 16.9% | 10.6% | -23.7% | -4.5% | 6.8% | 18.6% |
| EBIT | $-8.78M | $482000.00 | $-17.89M | $10.28M | $27.55M | $25.28M | $31.27M | $25.66M | $10.60M | $-177.00M | $-80.44M | $-10.33M | $58.55M |
| Interest expense | $11.46M | $11.97M | $14.23M | $15.94M | $18.90M | $19.17M | $21.58M | $9.75M | $1.11M | $12.02M | $40.68M | $38.79M | $26.49M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-22.37M | $-12.90M | $-34.11M | $-17.95M | $-1.64M | $-12.21M | $6.85M | $16.41M | $19.38M | $-158.70M | $-156.23M | $-33.54M | $22.73M |
| Net income growth (YoY) | — | +42.3% | -164.4% | +47.4% | +90.9% | -644.8% | +156.1% | +139.5% | +18.1% | -919.1% | +1.6% | +78.5% | +167.8% |
| Profit margin | -9.6% | -5.3% | -13.4% | -6.5% | -0.6% | -3.8% | 2.0% | 5.1% | 4.5% | -31.0% | -30.5% | -5.9% | 4.0% |